|
|
Curative Effect of Amiodarone Combined with Metoprolol in the Treatment of Acute Myocardial Infarction Complicated with Arrhythmia and Its Influence on Serum Inflammatory Factors Oxidative Stress and Vascular Endothelial Function |
HE Ruiying, LIAO Hui, LI Luna |
Chengdu Third People's Hospital,Sichuan Chengdu 610000,China |
|
|
Abstract Objective: To investigate the clinical effects of amiodarone combined with metoprolol in the treatment of acute myocardial infarction complicated with arrhythmia, and its influence on serum inflammatory factors, oxidative stress and vascular endothelial function. Methods: Totally 116 patients with acute myocardial infarction complicated with arrhythmia who were admitted to the hospital between September 2017 and October 2020 were randomly divided into amiodarone group (n=38), metoprolol group (n=38), and combination group (amiodarone combined with metoprolol, n=40). Serum inflammatory factors, oxidative stress, vascular endothelial function and adverse reactions were compared between the groups. Results: The total clinical response rate in the combination group (92.50%) was higher than that in the amiodarone group (78.95%) or the metoprolol group (76.32%) (P<0.05). After treatment, the levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), endothelin-1 (ET-1), von Willebrand factor (vWF), and malondialdehyde (MDA) were significantly decreased, while the levels of serum nitric oxide (NO), superoxide dismutase (SOD), and glutathione peroxidase (GPX) were significantly increased in the three groups. The decreases or increases of the combination group were significantly greater than those of the other two groups (P<0.05). The incidence of adverse reactions was 12.50% in the study group, 15.79% in the amiodarone group, and 18.42% in the metoprolol group (P>0.05). Conclusion: Amiodarone combined with metoprolol is markedly effective in the treatment of acute myocardial infarction complicated with arrhythmia. It can effectively reduce the levels of serum inflammatory factors, and improve oxidative stress response and vascular endothelial function in the patients, with good safety.
|
|
|
|
|
[1] 刘志立,宋菊,焦亚洲.急性心肌梗死病人血清miR-29b和miR-424的表达水平及其与预后的关系[J].中西医结合心脑血管病杂志,2020,18(7):1116-1120. [2] Bonde JPE, Flachs EM, Madsen IE,et al.Acute myocardial infarction in relation to physical activities at work:a nationwide follow-up study based on job-exposure matrices[J].Scand Work Environ Health,2020,46(3):268-277. [3] 王元明,郭任维,郭润民.胺碘酮对心律失常患者心功能、心率变异性及血清炎性因子水平的影响[J].中国临床药理学杂志,2020,36(7):737-740. [4] 刘磊,姚道阔,陈晖.冠状动脉微循环障碍发病机制研究进展[J].中国循证心血管医学杂志,2020,12(1):126-128. [5] 陆远,段洋,李志,等.艾司洛尔联合胺碘酮治疗急性心肌梗死合并快速型心律失常患者的疗效及对心电图的影响[J].临床内科杂志,2020,37(11):777-780. [6] 黄侃,史慧颖,王淑男,等.美托洛尔对大鼠心肌梗死后Th1平衡以及钾通道Kv2.1和KIR2.1表达的调控[J].中国免疫学杂志,2020,36(10):1173-1179,1184. [7] 李西红,孙黎博.胺碘酮联合美托洛尔治疗急性心肌梗死合并心律失常患者的效果及对患者心脏功能的影响分析[J].山西医药杂志,2019,48(22):2734-2737. [8] 苗孟丹,信栓力.炎症因子与急性心肌梗死后室性心律失常的关系[J].心血管康复医学杂志,2019,28(1):122-125. |
|
|
|